Fujifilm Pays $890M For Biogen Biologic Manufacturing Site
Fujifilm Holdings Corp. on Tuesday said a subsidiary will take over a Biogen-owned manufacturing site in Denmark in an $890 million deal, expanding the Tokyo-headquartered company's global biologics production and development...To view the full article, register now.
Already a subscriber? Click here to view full article